HLA-G and mother-child perinatal HIV transmission

Human Immunology

Volumn 74, Issue 4, 2013, Pages 459-463

  Luo, Ma ^a,b   Czarnecki, Chris ^b   Ramdahin, Suzie ^a   Embree, Joanne ^a   Plummer, Francis A ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ALLELE; ARTICLE; CHILD; EXON; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PERINATAL INFECTION; PHENOTYPE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ADULT; ALLELES; EXONS; FEMALE; GENOTYPING TECHNIQUES; HISTOCOMPATIBILITY, MATERNAL-FETAL; HIV INFECTIONS; HIV-1; HLA-G ANTIGENS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KENYA; PERINATAL CARE; POLYMORPHISM, GENETIC; PREGNANCY; PROTEIN ISOFORMS;

EID: 84875069872     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.11.023     Document Type: Article

References (50)

1. UNAIDS: http://www.unaids.org.
2. Fowler M.G. Update: transmission of HIV-1 from mother to child. Curr Opin Obstet Gynecol 1997, 9(6):343.
3. Li Q., Tsang B., Ding L., Ding Z.R. Vertical transmission of human immunodeficiency virus type 1: frequency and correlation of transmission (review). Int J Mol Med 1998, 1(3):589.
4. Jaffe H.W., Lifson A.R. Acquisition and transmission of HIV. Infect Dis Clin North Am 1988, 2(2):299.
5. Scarlatti G. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. AIDS Rev 2004, 6(2):67.
6. Embree J. The impact of HIV/AIDS on children in developing countries. Paediatr Child Health 2005, 10(5):261.
7. Datta P., Embree J.E., Kreiss J.K., Ndinya-Achola J.O., Braddick M., Temmerman M., et al. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis 1994, 170(5):1134.
8. Lehman D.A., Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 2007, 17(6):381.
9. Luzuriaga K., Sullivan J.L. Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev 2002, 4(1):21.
10. MacDonald K.S., Embree J.E., Nagelkerke N.J., Castillo J., Ramhadin S., Njenga S., et al. The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 2001, 183(3):503.
11. Polycarpou A., Ntais C., Korber B.T., Elrich H.A., Winchester R., Krogstad P., et al. Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses 2002, 18(11):741.
12. Aikhionbare F.O., Kumaresan K., Shamsa F., Bond V.C. HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther 2006, 3:28.
13. Aikhionbare F.O., Hodge T., Kuhn L., Bulterys M., Abrams E.J., Bond V.C. Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmission. Aids 2001, 15(16):2196.
14. Mackelprang R.D., John-Stewart G., Carrington M., Richardson B., Rowland-Jones S., Gao X., et al. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis 2008, 197(8):1156.
15. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996, 2(11):1240.
16. O'Brien T.R., Winkler C., Dean M., Nelson J.A., Carrington M., Michael N.L., et al. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 1997, 349(9060):1219.
17. van Manen D., Rits M.A., Beugeling C., van Dort K., Schuitemaker H., Kootstra N.A. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog 2008, 4(2):e18.
18. Sewram S., Singh R., Kormuth E., Werner L., Mlisana K., Karim S.S., et al. Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. J Infect Dis 2009, 199(11):1657.
19. Price H., Lacap P., Tuff J., Wachihi C., Kimani J., Ball T.B., et al. A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort. Aids 2008, 24(12):1813.
20. Hardie R.A., Luo M., Bruneau B., Knight E., Nagelkerke N.J., Kimani J., et al. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection. Aids 2008, 22(7):807.
21. MacDonald K.S., Fowke K.R., Kimani J., Dunand V.A., Nagelkerke N.J., Ball T.B., et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000, 181(5):1581.
22. Lacap P.A., Huntington J.D., Luo M., Nagelkerke N.J., Bielawny T., Kimani J., et al. Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort. Aids 2008, 22(9):1029.
23. Hardie R.A., Knight E., Bruneau B., Semeniuk C., Gill K., Nagelkerke N., et al. A common human leucocyte antigen-DP genotype is associated with resistance to HIV-1 infection in Kenyan sex workers. Aids 2008, 22(15):2038.
24. Lajoie J., Massinga Loembe M., Poudrier J., Guedou F., Pepin J., Labbe A.C., et al. Blood soluble human leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers. Hum Immunol 2010, 71(2):182.
25. Segat L., Catamo E., Fabris A., Morgutti M., D'Agaro P., Campello C., et al. HLA-G*0105N allele is associated with augmented risk for HIV infection in white female patients. Aids 2010, 24(12):1961.
26. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111(10):4862.
27. Favier B., LeMaoult J., Carosella E.D. Functions of HLA-G in the immune system. Tissue Antigens 2007, 69(Suppl. 1):150.
28. Hunt J.S., Petroff M.G., McIntire R.H., Ober C. HLA-G and immune tolerance in pregnancy. Faseb J 2005, 19(7):681.
29. van der Meer A., Lukassen H.G., van Cranenbroek B., Weiss E.H., Braat D.D., van Lierop M.J., et al. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod 2007, 13(2):123.
30. MacDonald K.S., Embree J., Njenga S., Nagelkerke N.J., Ngatia I., Mohammed Z., et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998, 177(3):551.
31. Luo M., Blanchard J., Pan Y., Brunham K., Brunham R.C. High-resolution sequence typing of HLA-DQA1 and -DQB1 exon 2 DNA with taxonomy-based sequence analysis (TBSA) allele assignment. Tissue Antigens 1999, 54(1):69.
32. Luo M., Blanchard J., Brunham K., Pan Y., Shen C.X., Lu H., et al. Two-step high resolution sequence-based HLA-DRB typing of exon 2 DNA with taxonomy-based sequence analysis allele assignment. Hum Immunol 2001, 62(11):1294.
33. Ho B.C., Laudette-Aboulhab J., Se-Thoe S.Y., Chan S.P., Ling A.E., Leo Y.S. Correlation of baseline quantitative plasma human immunodeficiency (HIV) type 1 RNA viral load with clinical status and CD4+ T-cell counts in treatment-naive HIV-positive patients in Singapore. Ann Acad Med Singapore 2000, 29(6):708.
34. Kannangai R., Ramalingam S., Jesudason M.V., Vijayakumar T.S., Abraham O.C., Zachariah A., et al. Correlation of CD4(+) T-Cell counts estimated by an immunocapture technique (Capcellia) with viral loads in human immunodeficiency virus-seropositive individuals. Clin Diagn Lab Immunol 2001, 8(6):1286.
35. Kuhn L., Aldrovandi G.M., Sinkala M., Kankasa C., Mwiya M., Thea D.M. Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to-child HIV transmission. Aids 2010, 24(9):1374.
36. Schmidt C.M., Ehlenfeldt R.G., Athanasiou M.C., Duvick L.A., Heinrichs H., David C.S., et al. Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription. J Immunol 1993, 151(5):2633.
37. Hviid T.V., Sorensen S., Morling N. Polymorphism in the regulatory region located more than 1.1 kilobases 5' to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene. Hum Immunol 1999, 60(12):1237.
38. Moreau P., Paul P., Gourand L., Prost S., Dausset J., Carosella E., et al. HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1. Hum Immunol 1997, 52(1):41.
39. Solier C., Mallet V., Lenfant F., Bertrand A., Huchenq A., Le Bouteiller P. HLA-G unique promoter region: functional implications. Immunogenetics 2001, 53(8):617.
40. Harrison G.A., Humphrey K.E., Jakobsen I.B., Cooper D.W. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993, 2(12):2200.
41. Hviid T.V., Hylenius S., Rorbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55(2):63.
42. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64(11):1005.
43. Hviid T.V., Rizzo R., Melchiorri L., Stignani M., Baricordi O.R. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006, 67(1-2):53.
44. Hiby S.E., King A., Sharkey A., Loke Y.W. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 1999, 53(1):1.
45. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72(4):335.
46. Yan W.H., Lin A., Chen X.J., Dai M.Z., Gan L.H., Zhou M.Y., et al. Association of the maternal 14-bp insertion polymorphism in the HLA-G gene in women with recurrent spontaneous abortions. Tissue Antigens 2006, 68(6):521.
47. Moreau P., Paul P., Rouas-Freiss N., Kirszenbaum M., Dausset J., Carosella E.D. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft. Am J Reprod Immunol 1998, 40(3):136.
48. Rizzo R., Hviid T.V., Govoni M., Padovan M., Rubini M., Melchiorri L., et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008, 71(6):520.
49. Rizzo R., Rubini M., Govoni M., Padovan M., Melchiorri L., Stignani M., et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006, 16(9):615.
50. Fabris A., Catamo E., Segat L., Morgutti M., Arraes L.C., de Lima-Filho J.L., et al. Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. Aids 2009, 23(2):177.